
Fusoh Pharmaceutical Industries (4538) Reports Earnings: Operating Profit Up 63.0% YoY to 972 Million Yen
StockClub
Published: Aug 10, 2026, 07:38 AM
Sentiment Analysis
Fusoh Pharmaceutical Industries (4538) has released its financial results, reporting net sales of 16,046 million yen, representing a 3.5% increase compared to the same period of the previous year. Profitability showed significant improvement, with operating profit surging 63.0% YoY to 972 million yen, ordinary profit rising 40.9% YoY to 911 million yen, and net profit increasing 39.0% YoY to 642 million yen.
Regarding the financial position and cash flows, the equity ratio stands at 40.9% with cash and cash equivalents of 4,850 million yen. Interest-bearing debt is recorded at 26,310 million yen and retained earnings stand at 1,388 million yen. Operating cash flow was -6,220 million yen and free cash flow was -7,740 million yen. While cash outflows related to investments and working capital are observed, investors will continue to monitor the company's capital allocation and ongoing financial management.
This content is not intended as investment advice or a recommendation. Any opinions expressed are solely the personal views of each article.